AzTrials
AzTrials

Pediatric Hospital DischargeTeleDOCNCT05156840

Telehealth for Discharge Outcomes in Children

An observational study of Pediatric Hospital Discharge and Telehealth, run by University of California, Davis.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

This study will test the feasibility of a telehealth follow-up visit for patients and their caregivers who were recently discharged from a general pediatric inpatient unit. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Pediatric Hospital Discharge, Telehealth
What is being tested?
Telehealth follow-up
How many people
0 participants
Where
No sites listed yet
Study dates
20 Jan 2023to 1 May 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: This study will conduct surveys and interviews to evaluate the feasibility of a telehealth follow-up visit between parents/guardians and pediatric hospitalists of children discharged from the University of California Davis Children's Hospital's pediatric hospitalist service. Telehealth follow-up visits will be offered to discharging pediatric patients at the discretion of the pediatric hospitalist who is discharging the patient.

Who may be able to join

  • Parents/legal guardians of patients recently discharged from the University of California Davis Children's Hospital pediatric hospitalist service, who were offered a telehealth follow-up visit following their child's discharge
  • Pediatric hospitalists who discharged the above patients and offered a telehealth follow-up visit following discharge

Who cannot join

  • Parents/legal guardians of children discharged from an intensive care or subspecialty service

About this study

Official title: Telehealth for Discharge Outcomes in Children: A Feasibility Study

This study will test the feasibility of a telehealth follow-up visit for patients and their caregivers who were recently discharged from a general pediatric inpatient unit.

Read the detailed description

Patient transitions from hospital to home have increasingly become recognized as a critical opportunity to promote patient safety and high quality care, both at University of California Davis Medical Center and nationwide. With over 16,000 children discharged from U.S. hospitals each day and a rate of 1 in 5 experiencing adverse events related to this process, it is estimated that hospital-to-home transition-related adverse events affect over 1.1 million children annually. The quality of hospital discharge also affects hospital readmission rates, length of hospital stay, and parental satisfaction.

Discharge transition difficulties stem largely from care coordination failures throughout the hospital-to-home transition. The investigators recently conducted a qualitative study analyzing perspectives from parents and physicians of 20 children readmitted within 30 days of hospital discharge. The study identified a theme of caregivers having difficulty re-connecting to the child's medical team for ongoing care after discharge. When problems arose, caregivers reported challenges in knowing who to contact, when to reach out for help, and how to navigate the health system to prevent readmission.

The advent of telehealth presents a unique opportunity to provide seamless follow-up for families following hospital discharge. Although telehealth has not previously been studied as a means of providing pediatric follow-up care after hospital discharge, similar methods of providing post-discharge hospital follow-up, including nurse- or physician-led phone calls and nurse home visits, were highly regarded by families, but failed to impact readmission rates. Telehealth provides a unique advantage over these alternate interventions by allowing face-to-face interaction via videoconference between the patient, caregiver, and hospital physician, who is already familiar with the patient's disease course and overall trajectory. At the investigators' site, although telehealth is readily available for use in most any clinical setting, it is not commonly used for hospital discharge follow-up. Therefore, this study proposes to test the feasibility of a telehealth follow-up visit for patients and their caregivers who were recently discharged from a general pediatric inpatient unit.

Being tested
Telehealth follow-up
Keywords
telehealth, hospital discharge, pediatric, telemedicine

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Telehealth follow-upBehavioural

    A telehealth follow-up visit will be conducted via the Epic electronic medical record with a pediatric hospitalist following hospital discharge.

Study groups in NCT05156840
Study groupRoleWhat they receive
TelehealthPatients/Caregivers who received a telehealth follow-up visit from a pediatric hospitalist following hospital discharge.
Receives: Behavioral: Telehealth follow-up
Usual CarePatients/Caregivers who did not receive a telehealth follow-up visit from a pediatric hospitalist following hospital discharge.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Feasibility Objective 1: Telehealth visit offered on hospital discharge

    This objective will assess what percentage of patients discharged from the pediatric hospital medicine service were offered a telehealth follow-up visit on hospital discharge.

    Measured: Within 7 days of hospital discharge

  2. Feasibility Objective 2: Parent agreement to engage in telehealth visit

    This objective will assess what percentage of parents who were offered a telehealth visit following hospital discharge agreed to participate.

    Measured: Within 7 days of hospital discharge

  3. Feasibility Objective 3: Successful completion of telehealth

    This objective will assess what percentage of scheduled telehealth visits were successfully completed, as reported by the involved pediatric hospitalist.

    Measured: Within 14 days of hospital discharge

  4. Feasibility Objective 4: Lack of technical issues

    This objective will assess what percentage of scheduled telehealth visits had not technical issues, as reported by both the involved pediatric hospitalist and the involved caregiver.

    Measured: Within 14 days of hospital discharge

  5. Feasibility Objective 5: Survey response rates

    This objective will assess what percentage of surveys administered to both pediatric hospitalists and caregivers were completed.

    Measured: Within 30 days of hospital discharge

Secondary outcomes (3)
  1. Hospital Readmission

    This secondary outcome will assess 30-day hospital re-admission rates, by parental report.

    Measured: Within 30 days of hospital discharge

  2. Hospital Length of Stay

    This secondary outcome will assess hospital length of stay. This information will be extracted from the electronic medical record.

    Measured: Within 7 days of hospital discharge

  3. 3-Item Care Transitions Measure

    This secondary outcome will evaluate parent scores on the 3-item Care Transitions Measure, reflecting on their child's recent care transition from hospital to home. The 3-question survey include 4 answer choices from 1 (strongly disagree) to 4 (strongly agree), with higher scores indicated a better outcome.

    Measured: Within 30 days of hospital discharge

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Dec 2021
  2. Study start20 Jan 2023
  3. Primary completion1 May 2023 (estimated)
  4. Study completion1 May 2023

Why it stopped: No interested participants were recruited within a 4 month period.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05156840
Sponsor's protocol ID
1845410
Acronym
TeleDOC
Status last verified
Sep 2024
First submitted
1 Dec 2021
Last updated
23 Sep 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Pediatric Hospital Discharge and Telehealth, run by University of California, Davis.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 23 Sep 2024. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Feasibility Objective 1: Telehealth visit offered on hospital discharge (time frame: Within 7 days of hospital discharge). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Sep 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in